Effect of Routine Cytochrome P450 2D6 and 2C19 Genotyping on Antipsychotic Drug Persistence in Patients With SchizophreniaGesche Jűrgens, Merete Nordentoft, Benjamin Skov Kaas‐Hansen et al.|JAMA Network Open|2020Cited by 31
A systematic review of pharmacogenetic testing to guide antipsychotic treatmentNoushin Saadullah Khani, Elvira Bramon, Manuel Franco et al.|Nature Mental Health|2024Cited by 28
Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled TrialsNiels Graudal, Gesche Jűrgens, Benjamin Skov Kaas‐Hansen et al.|International Journal of Molecular Sciences|2019Cited by 22
Language‐agnostic pharmacovigilant text mining to elicit side effects from clinical notes and hospital medication recordsBenjamin Skov Kaas‐Hansen, Stig Ejdrup Andersen, Davide Placido et al.|Basic & Clinical Pharmacology & Toxicology|2022Cited by 7
Is the CYP2D6 Genotype Associated with Antipsychotic-Induced Weight Gain?Gesche Jűrgens, Stig Ejdrup Andersen, Benjamin Skov Kaas‐Hansen et al.|Journal of Personalized Medicine|2022Cited by 3